The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...

The series A financing will enable Nura Bio to advance its lead drug candidate into the next stage of clinical trials, ...

Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.

Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have ...

Applying AI-enabled route scouting services allows drug developers to avoid pitfalls that can typically occur in drug ...

Motif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its ...

The European Organisation for Research and Treatment of Cancer (EORTC) has renewed and extended its partnership with Medidata ...

Creyon Bio Inc., a clinical-stage biotechnology company specializing in AI and machine learning-enabled oligonucleotide-based ...

Beate Mueller-Tiemann is chief technology officer at Cytiva. With a passion for science and an ‘eternal technology optimist’, ...

Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligence’s (AI's) ...

Emmanuelle Cameau is strategic technology partnership leader at Cytiva. Read our interview to discover how losing her beloved ...